- P-ISSN 1225-0163
- E-ISSN 2288-8985
- Apply for Authority
- P-ISSN1225-0163
- E-ISSN2288-8985
- SCOPUS, ESCI, KCI
Article Detail
Home > Article Detail
Development and validation of a qualitative GC-MS method for THCCOOH in urine using injection-port derivatization
Analytical Science and Technology / Analytical Science and Technology, (P)1225-0163; (E)2288-8985
2021, v.34 no.2, pp.68-77
https://doi.org/10.5806/AST.2021.34.2.68
(Forensic Genetics & Chemistry Division, Supreme Prosecutors’ Office and Kyungsung University)
(Forensic Genetics & Chemistry Division, Supreme Prosecutors’ Office)
(Forensic Genetics & Chemistry Division, Supreme Pr)
(Forensic Genetics & Chemistry Division, Supreme Prosecutors’ Office)
(Forensic Genetics & Chemistry Division, Supreme Pr)
Yeong,
E.
S.
, Ji,
W.
K.
, &
Jin,
Y.
K.
(2021). Development and validation of a qualitative GC-MS method for THCCOOH in urine using injection-port derivatization. Analytical Science and Technology, 34(2), 68-77, https://doi.org/10.5806/AST.2021.34.2.68
- Downloaded
- Viewed
Abstract
Cannabis is one of the most abused drugs in Korea. The main psychoactive component in cannabis, Δ9-tetrahydrocannabinol, is metabolized to 11-nor-9-carboxy-Δ9-tetrahydrocannabinol (THCCOOH) and THCCOOHglucuronide (THCCOOH-glu) in the human liver, whereby the amount of THCCOOH-glu found in urine is twice as high as that of THCCOOH. The analytical process adapted by the majority of urine drug-testing programs involves a two-step method consisting of an initial immunoassay-based screening test followed by a confirmatory test if the screening test result is positive. In this study, a qualitative gas chromatography-mass spectrometry (GC-MS) method was developed and validated for the detection of THCCOOH in human urine, where THCCOOH-glu was converted into THCCOOH by alkaline hydrolysis. For purification of the urine extract prior to instrumental analysis, high-speed centrifugation was used to minimize interference. In addition, an injection-port derivatization method using ethyl acetate and N,O-bis(trimethylsilyl)-trifluoroacetamide containing 1 % trimethylchlorosilane was employed to reduce the time required for derivatization, and an aliquot of the final solution was injected into the GC-MS. The method was validated by measuring the selectivity, limit of detection (LOD), and repeatability. The sensitivity, specificity, precision, accuracy, Kappa, F-measure, false positive, and false negative rate were determined by comparing the GC-MS results with those obtained using the immunoassay. The LOD was determined to be 0.32 ng/mL, while the repeatability was within 9.1 % for THCCOOH. Furthermore, a comparison study was carried out, whereby the screening immunoassay exhibited a sensitivity of 86.4 % and a specificity of 100 % compared to GC-MS. The applicability of the developed method was examined by analyzing spiked urine and forensic urine samples obtained from suspected cannabis abusers (n = 221).
- keywords
- qualitative analysis, validation, injection-port derivatization, urinary THCCOOH, GC-MS
Reference
1
1. K. M. Heo, Korean Police Studies Review, 17, 291-316(2018).
2
2. Korea Customs Service, ‘Announcement of Drug Smuggling Trends and Countermeasures in 2018’, Korea, 2019.
3
3. Supreme Prosecutors’ Office, ‘White paper on drugrelated crimes 2019-Chapter 2’, Seoul, Korea, 2020.
4
4. S. Foley, J. R. Karlsen and T. J. Putninņš, Rev. Financ. Stud., 32, 1798-1853 (2019).
5
5. M. Hädener, W. Weinmann, D. R. van Staveren and S. König, Bioanalysis, 9, 485-496 (2017).
6
6. P. M. Kemp, I. K. Abukhalaf, J. E. Manno, B. R. Manno, D. D. Alford, M. E. McWilliams, F. E. Nixon, M. J. Fitzgerald, R. R. Reeves and M. J. Wood, J. Anal. Toxicol., 19, 292-298 (1995).
7
7. M. M. Bergamaschi, A. Barnes, R. H. C. Queiroz, Y. L. Hurd and M. A. Huestis, Anal. Bioanal. Chem., 405, 4679-4689 (2013).
8
8. O. Aizpurua-Olaizola, I. Zarandona, L. Ortiz, P. Navarro, N. Etxebarria and A. Usobiaga, Drug Test. Anal., 9, 626-633 (2017).
9
9. W. Kwon, J. Y. Kim, S. Suh and M. K. In, Anal. Methods, 5, 3028-3034 (2013).
10
10. G. M. Reisfield, B. A. Goldberger and R. L. Bertholf, Bioanalysis, 1, 937-952 (2009).
11
11. A. Saitman, H. D. Park and R. L. Fitzgerald, J. Anal. Toxicol., 38, 387-396 (2014).
12
12. A. D. de Jager and N. L. Bailey, J. Chromatogr. B, 879, 2642-2652 (2011).
13
13. S. J. Mulé and G. A. Casella, J. Anal. Toxicol., 12, 102-107 (1988).
14
14. D. K. Lee, M. H. Yoon, Y. P. Kang, J. Yu, J. H. Park, J. Lee and S. W. Kwon, Food Chem., 141, 3931-3937 (2013).
15
15. J. M. Halket, D. Waterman, A. M. Przyborowska, R. K. Patel, P. D. Fraser and P. M. Bramley, J. Exp. Bot., 56, 219-243 (2005).
16
16. Q. Wang, L. Ma, C. R. Yin and L. Xu, J. Chromatogr. A, 1296, 25-35 (2013).
17
17. J. Wu and H. K. Lee, Anal. Chem., 78, 7292-7301(2006).
18
18. A. Marsol-Vall, M. Balcells, J. Eras and R. CanelaGarayoa, Food Chem., 204, 210-217 (2016).
19
19. A. Marsol-Vall, M. Balcells, J. Eras and R. CanelaGarayoa, J. Chromatogr. A, 1453, 99-104 (2016).
20
20. A. F. Oliveira, E. C. de Figueiredo and A. J. Dos SantosNeto, J. Pharm. Biomed. Anal., 73, 53-58 (2013).
21
21. K. F. da Cunha, R. Lanaro, A. F. Martins, K. D. Oliveira and J. L. Costa, Forensic Toxicol., 39, 222-229 (2021).
22
22. R. Fogerson, D. Schoendorfer, J. Fay and V. Spiehler, J. Anal. Toxicol., 21, 451-458 (1997).
23
23. P. S. Cheng, C. Y. Fu, C. H. Lee, C. Liu and C. S. Chien, J. Chromatogr. B, 852, 443-449 (2007).
24
24. M. Gaugain-Juhel, B. Delépine, S. Gautier, M.P. Fourmond, V. Gaudin, D. Hurtaud-Pessel, E. Verdon and P. Sanders, Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess, 26, 1459-1471 (2009).
25
25. S. P. Elliott, D. W. S. Stephen and S. Paterson, Sci. Justice, 58, 335-345 (2018).
26
26. M. A. ElSohly, ‘Marijuana and the cannabinoids, Chapter 7’, Humana Press, Totowa, New Jersey, USA, 2007.
27
27. A. J. Barnes, I. Kim, R. Schepers, E. T. Moolchan, L. Wilson, G. Cooper, C. Reid, C. Hand and M. A. Huestis, J. Anal. Toxicol., 27, 402-407 (2003).
28
28. J. C. Cheong, J. Y. Kim, M. K. In and W. J. Cheong, Anal. Sci. Technol., 19, 441-448 (2006).
29
29. J. M. Halket and V. G. Zaikin, Eur. J. Mass Spectrom., 9, 1-21 (2003).
Other articles from this issue
- Development of Jaspine B analysis using LC-MS/MS and its application: Dose-independent pharmacokinetics of Jaspine B in rats
- Gliclazide compatibility with some common chemically reactive excipients; using different analytical techniques
- A preliminary study of semi-quantitative, comparative evaluation of split or half fingerprints using Densitometric Image Analysis (DIA) - Inter-analyst differences for split or half fingerprints -
- Development and validation of a qualitative GC-MS method for THCCOOH in urine using injection-port derivatization
- Determination of cut-off value by receiver operating characteristic curve of norquetiapine and 9-hydroxyrisperidone concentrations in urine measured by LC-MS/MS
- Development of a nanoparticle multi-generator for assessment of inhalation hazard
- more
Recommanded Articles
This website recommended the use the Chrome browser for journal website.